...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith-Oncology Pipeline

,,hummmm,,great posts by all,,,,,I am not sure present shareholders would bail if we went to the nasdaq,,,,,I dont think I would until at least trial data tells me to!!,,,,....what I see moving up to a respected exchange is,,,,,, large investor base,,,, access to the company by US funds and beyond.....visibility,,,,,,,liquidity,,,etc,,the only issue would be the size of the ball gag we would need for DMcC,,,!!!!,,,,,most of us will have our estate in probate before this team might actually build shareholder value at any rate,,,and value might still be only be met by accident!!!,,at least we have some sort of business plan going in Zenith,,unlike RVX,,but most likely only because professionals BPs are involved!! No nonsense aspirations out of our partners!!,,They are interested in hard fact rest assured!

Share
New Message
Please login to post a reply